Intranasal nanoparticle drug delivery to promote functional recovery in multiple sclerosis
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210918
- Recipient
-
Dalhousie University UEI C1FXPHMHR966
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $183,711
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $183,711 Project Grant to Dalhousie University through the Military Medical Research and Development program (CFDA 12.420). The grant supports research into intranasal nanoparticle drug delivery to promote functional recovery in multiple sclerosis. The Military Medical Research and Development program aims to transform military and public health care through innovative biomedical research, including investigating medical solutions for battlefield wounds. Dalhousie University will conduct this research from September 30, 2022 to September 29, 2024 to develop minimally invasive drug delivery methods that could improve outcomes for those with multiple sclerosis.
Quick answers
Who received award W81XWH2210918?
W81XWH2210918 was awarded to Dalhousie University by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210918 worth?
$183,711 has been obligated on W81XWH2210918.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award